FIELD: chemistry.
SUBSTANCE: invention relates to novel N-arylacetamide derivatives of 2-thiouracil of the general formula indicated below having an antiviral effect against human adenoviruses. In general formula
X = bond or CH2; R1=H, CH3, CH2C6H5 or (CH2)2OC6H5; R2=H, CH3, C2H5, C3H7, CH(CH3)2, CH2OCH2(p-CH3C6H4), CH2OCH(C6H5)2, CH2O(CH2)2OC6H5 or CH2N(CH3)C6H5; R1+R2=CH=CH-CH=CH; R3=H or CH3; R4=H, OC4H9, C6H5, CH2C6H5, C(O)C6H5 or OAr; Ar=C6H5, C6H4R5 or C6H3(R5)2; R5=o-, m-, p-Cl, Br, CH3, C(CH3)3 or 1-C10H7.
EFFECT: invention has an antiviral effect against human adenoviruses.
1 cl, 1 dwg, 3 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-(CHROMENO[4,3-D]PYRIMIDIN-5-YL)ACETIC ACID DERIVATIVES AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2716597C1 |
| METHOD FOR PREPARING AMMONIUM SALTS OF 3-AMINO-8-HYDROXY-1,6-DIOXO-4-CYANO-2,7-DIAASPIRO [4,4] NON-3-EN-2-IDS | 2016 |
|
RU2631856C1 |
| QUATERNARY AMMONIUM SALTS BASED ON DERIVATIVES OF VITAMIN B6 | 2015 |
|
RU2607522C1 |
| LIGANDS, TROPIC TO PROSTATIC SPECIFIC MEMBRANE ANTIGEN AND USE THEREOF FOR OBTAINING DOUBLE CONJUGATES WITH THERAPEUTIC AGENTS BASED THEREON FOR COMBINED THERAPY OF PSMA EXPRESSING TUMOURS | 2023 |
|
RU2841078C1 |
| TRIALLILBORANE ADDUCTS WITH AMMONIA AND AMINES AS ALLYLATING REAGENTS | 2018 |
|
RU2678208C1 |
| DERIVATIVES OF 3-AMINOMETHYLQUINOLONE-2 AS INHIBITORS OF NO-SYNTHETASE AND METHOD FOR THEIR PREPARING, BIOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2267485C2 |
| SUBSTITUTED (2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATES | 2013 |
|
RU2553996C1 |
| SPIRO CONDENSED DERIVATIVES OF 2,3-DIHYDROINDOLE, THEIR USE IN OPHTHALMOLOGY | 2017 |
|
RU2712039C2 |
| METHOD OF PRODUCING ALKYL-SUBSTITUTED 2-OXO-1,2-DIHYDROPYRIDINE-3,4-DICARBONITRILES | 2015 |
|
RU2577526C1 |
| DERIVATIVES OF PIPERAZINE, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2179554C2 |
